Literature DB >> 9708800

Expression of the vascular endothelial growth factor C receptor VEGFR-3 in lymphatic endothelium of the skin and in vascular tumors.

A Lymboussaki1, T A Partanen, B Olofsson, J Thomas-Crusells, C D Fletcher, R M de Waal, A Kaipainen, K Alitalo.   

Abstract

It is difficult to identify lymph vessels in tissue sections by histochemical staining, and thus a specific marker for lymphatic endothelial cells would be more practical in histopathological diagnostics. Here we have applied a specific antigenic marker for lymphatic endothelial cells in the human skin, the vascular endothelial growth factor receptor-3 (VEGFR-3), and show that it identifies a distinct vessel population both in fetal and adult skin, which has properties of lymphatic vessels. The expression of VEGFR-3 was studied in normal human skin by in situ hybridization, iodinated ligand binding, and immunohistochemistry. A subset of developing vessels expressed the VEGFR-3 mRNA in fetal skin as shown by in situ hybridization and radioiodinated vascular endothelial growth factor (VEGF)-C bound selectively to a subset of vessels in adult skin that had morphological characteristics of lymphatic vessels. Monoclonal antibodies against the extracellular domain of VEGFR-3 stained specifically endothelial cells of dermal lymph vessels, in contrast to PAL-E antibodies, which stained only blood vessel endothelia. In addition, staining for VEGFR-3 was strongly positive in the endothelium of cutaneous lymphangiomatosis, but staining of endothelial cells in cutaneous hemangiomas was weaker. These results establish the utility of anti-VEGFR-3 antibodies in the identification of lymphovascular channels in the skin and in the differential diagnosis of skin lesions involving lymphatic or blood vascular endothelium.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9708800      PMCID: PMC1852985          DOI: 10.1016/S0002-9440(10)65583-6

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  33 in total

Review 1.  Angiogenesis.

Authors:  J Folkman; Y Shing
Journal:  J Biol Chem       Date:  1992-06-05       Impact factor: 5.157

2.  The extension technique: a new method of demonstrating initial lymph vessels in excised human skin.

Authors:  D Lubach; A Wawrzyniak-Schulz; D Neukam; S Nissen
Journal:  Br J Dermatol       Date:  1990-08       Impact factor: 9.302

3.  A histologic atlas of vascular lesions.

Authors:  T R Wade; H Kamino; A B Ackerman
Journal:  J Dermatol Surg Oncol       Date:  1978-11

4.  Laminin and type IV collagen in different histological stages of Kaposi's sarcoma and other vascular lesions of blood vessel or lymphatic vessel origin.

Authors:  H Autio-Harmainen; T Karttunen; M Apaja-Sarkkinen; K Dammert; L Risteli
Journal:  Am J Surg Pathol       Date:  1988-06       Impact factor: 6.394

5.  A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit.

Authors:  W Matthews; C T Jordan; M Gavin; N A Jenkins; N G Copeland; I R Lemischka
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

6.  Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4).

Authors:  M G Achen; M Jeltsch; E Kukk; T Mäkinen; A Vitali; A F Wilks; K Alitalo; S A Stacker
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-20       Impact factor: 11.205

7.  Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor.

Authors:  D Maglione; V Guerriero; G Viglietto; P Delli-Bovi; M G Persico
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

8.  FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines.

Authors:  K Pajusola; O Aprelikova; J Korhonen; A Kaipainen; L Pertovaara; R Alitalo; K Alitalo
Journal:  Cancer Res       Date:  1992-10-15       Impact factor: 12.701

9.  The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor.

Authors:  C de Vries; J A Escobedo; H Ueno; K Houck; N Ferrara; L T Williams
Journal:  Science       Date:  1992-02-21       Impact factor: 47.728

10.  Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor.

Authors:  B I Terman; M Dougher-Vermazen; M E Carrion; D Dimitrov; D C Armellino; D Gospodarowicz; P Böhlen
Journal:  Biochem Biophys Res Commun       Date:  1992-09-30       Impact factor: 3.575

View more
  38 in total

1.  The beta-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors.

Authors:  R J Nibbs; E Kriehuber; P D Ponath; D Parent; S Qin; J D Campbell; A Henderson; D Kerjaschki; D Maurer; G J Graham; A Rot
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

2.  Vascular endothelial growth factor-C promotes alloimmunity by amplifying antigen-presenting cell maturation and lymphangiogenesis.

Authors:  Amir R Hajrasouliha; Toshinari Funaki; Zahra Sadrai; Takaaki Hattori; Sunil K Chauhan; Reza Dana
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-03-09       Impact factor: 4.799

3.  D2-40 staining in sinonasal-type hemangiopericytoma--further evidence of distinction from conventional hemangiopericytoma and solitary fibrous tumor.

Authors:  Torsten Hansen; Kathrin Katenkamp; Detlef Katenkamp
Journal:  Virchows Arch       Date:  2005-12-16       Impact factor: 4.064

4.  Vascular endothelial growth factor D is dispensable for development of the lymphatic system.

Authors:  Megan E Baldwin; Michael M Halford; Sally Roufail; Richard A Williams; Margaret L Hibbs; Dianne Grail; Hajime Kubo; Steven A Stacker; Marc G Achen
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

5.  Vascular endothelial growth factor C induces angiogenesis in vivo.

Authors:  Y Cao; P Linden; J Farnebo; R Cao; A Eriksson; V Kumar; J H Qi; L Claesson-Welsh; K Alitalo
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

6.  Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer.

Authors:  Sebastian F Schoppmann; Guenther Bayer; Klaus Aumayr; Susanne Taucher; Silvana Geleff; Margaretha Rudas; Ernst Kubista; Hubert Hausmaninger; Hellmut Samonigg; Michael Gnant; Raimund Jakesz; Reinhard Horvat
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

7.  Organ-specific lymphangiectasia, arrested lymphatic sprouting, and maturation defects resulting from gene-targeting of the PI3K regulatory isoforms p85alpha, p55alpha, and p50alpha.

Authors:  Carla Mouta-Bellum; Aleksander Kirov; Laura Miceli-Libby; Maria L Mancini; Tatiana V Petrova; Lucy Liaw; Igor Prudovsky; Philip E Thorpe; Naoyuki Miura; Lewis C Cantley; Kari Alitalo; David A Fruman; Calvin P H Vary
Journal:  Dev Dyn       Date:  2009-10       Impact factor: 3.780

8.  Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma.

Authors:  N Dupin; C Fisher; P Kellam; S Ariad; M Tulliez; N Franck; E van Marck; D Salmon; I Gorin; J P Escande; R A Weiss; K Alitalo; C Boshoff
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

9.  Cholangiocarcinoma pathogenesis: Role of the tumor microenvironment.

Authors:  Dinorah Leyva-Illades; Matthew McMillin; Matthew Quinn; Sharon Demorrow
Journal:  Transl Gastrointest Cancer       Date:  2012

10.  Expression of vascular endothelial growth factors A and C in human pancreatic cancer.

Authors:  Rui-Feng Tang; Shu-Xia Wang; Li Peng; Shun-Xiang Wang; Meng Zhang; Zhi-Feng Li; Zhi-Ming Zhang; Yan Xiao; Feng-Rui Zhang
Journal:  World J Gastroenterol       Date:  2006-01-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.